Madrigal Pharmaceuticals: Boom Or Bust In MASH? Regretfully, I'm Bearish
Source: SeekingAlpha
2026-04-28 14:27:46 ET
Investment Overview
In January this year, I downgraded my rating on Madrigal Pharmaceuticals, Inc. ( MDGL ) from a Buy to a Hold. A good decision, as it turns out, because while stock is up >45% since my February 2025 Buy call , it is down >10% since I downgraded to Hold....
Read the full article on Seeking Alpha
For further details see:
Madrigal Pharmaceuticals: Boom Or Bust In MASH? Regretfully, I'm Bearish
Madrigal Pharmaceuticals Inc.
NASDAQ: MDGL
MDGL Trading
2.23% G/L:
$475.43 Last:
102,868 Volume:
$450.61 Open:
MDGL Latest News
June 03, 2026 08:00:00 am
Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026
May 27, 2026 08:00:00 am
Madrigal Presents Data Demonstrating Rezdiffra Reduced Markers of Cardiovascular and Liver-Related Risk in Patients with MASH
MDGL Stock Data
$10,921,013,421
11,446,556
2.73%
146
N/A
Biotechnology & Life Sciences
Healthcare
US
West Conshohocken
